Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPB vs ESPB with Dexmedetomidine for Mastectomy Pain
NCT06737458Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine and dexmedetomidine in postoperative pain (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Total dose of pethidine consumption. Started Jul 2023; status: completed.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06737458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06737458.